Novel small molecule inhibitors of PTP1B

M. V V V Sekhar Reddy, G. Chakshusmathi, Lakshmi M. Narasu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Protein tyrosine phosphatase is a classical non receptor tyrosine phosphotase enzyme and is an important regulator in several signaling pathways including insulin and leptin. PTP1B is a negative regulator of insulin receptor (IR) which dephosphorylates tyrosine residues of Insulin Receptor tyrosine Kinase (IRK) domain and induces resistance to insulin sensitivity and obesity up on over expression of PTP1B. Thus PTP1B is a vital therapeutic target for Type II diabetes and developing a selective PTP1B inhibitor is an essential breakthrough in controlling the disease which has been afflicting 1/3rd of world population. We have identified few small molecule PTP1B inhibitors which have shown micro molar range inhibition by in vitro pNPP assay method.

Original languageEnglish (US)
Pages (from-to)412-417
Number of pages6
JournalInternational Journal of Pharma and Bio Sciences
Volume3
Issue number2
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Protein Tyrosine Phosphatases
Insulin Receptor
Leptin
Type 2 Diabetes Mellitus
Tyrosine
Insulin Resistance
Obesity
Insulin
Molecules
Enzymes
Medical problems
Population
Assays
Therapeutics
tyrosine receptor
insulin receptor tyrosine kinase
In Vitro Techniques

Keywords

  • Ir: insulin receptor
  • Irk: insulin receptor kinase
  • Pnpp: Para Nitro Phenol Pyrophosphate

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Molecular Biology
  • Cell Biology

Cite this

Sekhar Reddy, M. V. V. V., Chakshusmathi, G., & Narasu, L. M. (2012). Novel small molecule inhibitors of PTP1B. International Journal of Pharma and Bio Sciences, 3(2), 412-417.

Novel small molecule inhibitors of PTP1B. / Sekhar Reddy, M. V V V; Chakshusmathi, G.; Narasu, Lakshmi M.

In: International Journal of Pharma and Bio Sciences, Vol. 3, No. 2, 04.2012, p. 412-417.

Research output: Contribution to journalArticle

Sekhar Reddy, MVVV, Chakshusmathi, G & Narasu, LM 2012, 'Novel small molecule inhibitors of PTP1B', International Journal of Pharma and Bio Sciences, vol. 3, no. 2, pp. 412-417.
Sekhar Reddy MVVV, Chakshusmathi G, Narasu LM. Novel small molecule inhibitors of PTP1B. International Journal of Pharma and Bio Sciences. 2012 Apr;3(2):412-417.
Sekhar Reddy, M. V V V ; Chakshusmathi, G. ; Narasu, Lakshmi M. / Novel small molecule inhibitors of PTP1B. In: International Journal of Pharma and Bio Sciences. 2012 ; Vol. 3, No. 2. pp. 412-417.
@article{12749b9eb8894dccbcf23aafa45ece9b,
title = "Novel small molecule inhibitors of PTP1B",
abstract = "Protein tyrosine phosphatase is a classical non receptor tyrosine phosphotase enzyme and is an important regulator in several signaling pathways including insulin and leptin. PTP1B is a negative regulator of insulin receptor (IR) which dephosphorylates tyrosine residues of Insulin Receptor tyrosine Kinase (IRK) domain and induces resistance to insulin sensitivity and obesity up on over expression of PTP1B. Thus PTP1B is a vital therapeutic target for Type II diabetes and developing a selective PTP1B inhibitor is an essential breakthrough in controlling the disease which has been afflicting 1/3rd of world population. We have identified few small molecule PTP1B inhibitors which have shown micro molar range inhibition by in vitro pNPP assay method.",
keywords = "Ir: insulin receptor, Irk: insulin receptor kinase, Pnpp: Para Nitro Phenol Pyrophosphate",
author = "{Sekhar Reddy}, {M. V V V} and G. Chakshusmathi and Narasu, {Lakshmi M.}",
year = "2012",
month = "4",
language = "English (US)",
volume = "3",
pages = "412--417",
journal = "International Journal of Pharma and Bio Sciences",
issn = "0975-6299",
publisher = "International Journal of Pharma and Bio Sciences",
number = "2",

}

TY - JOUR

T1 - Novel small molecule inhibitors of PTP1B

AU - Sekhar Reddy, M. V V V

AU - Chakshusmathi, G.

AU - Narasu, Lakshmi M.

PY - 2012/4

Y1 - 2012/4

N2 - Protein tyrosine phosphatase is a classical non receptor tyrosine phosphotase enzyme and is an important regulator in several signaling pathways including insulin and leptin. PTP1B is a negative regulator of insulin receptor (IR) which dephosphorylates tyrosine residues of Insulin Receptor tyrosine Kinase (IRK) domain and induces resistance to insulin sensitivity and obesity up on over expression of PTP1B. Thus PTP1B is a vital therapeutic target for Type II diabetes and developing a selective PTP1B inhibitor is an essential breakthrough in controlling the disease which has been afflicting 1/3rd of world population. We have identified few small molecule PTP1B inhibitors which have shown micro molar range inhibition by in vitro pNPP assay method.

AB - Protein tyrosine phosphatase is a classical non receptor tyrosine phosphotase enzyme and is an important regulator in several signaling pathways including insulin and leptin. PTP1B is a negative regulator of insulin receptor (IR) which dephosphorylates tyrosine residues of Insulin Receptor tyrosine Kinase (IRK) domain and induces resistance to insulin sensitivity and obesity up on over expression of PTP1B. Thus PTP1B is a vital therapeutic target for Type II diabetes and developing a selective PTP1B inhibitor is an essential breakthrough in controlling the disease which has been afflicting 1/3rd of world population. We have identified few small molecule PTP1B inhibitors which have shown micro molar range inhibition by in vitro pNPP assay method.

KW - Ir: insulin receptor

KW - Irk: insulin receptor kinase

KW - Pnpp: Para Nitro Phenol Pyrophosphate

UR - http://www.scopus.com/inward/record.url?scp=84869181082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869181082&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 412

EP - 417

JO - International Journal of Pharma and Bio Sciences

JF - International Journal of Pharma and Bio Sciences

SN - 0975-6299

IS - 2

ER -